These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 26547260)

  • 1. YM155 suppresses cell proliferation and induces cell death in human adult T-cell leukemia/lymphoma cells.
    Sasaki R; Ito S; Asahi M; Ishida Y
    Leuk Res; 2015 Dec; 39(12):1473-9. PubMed ID: 26547260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol suppresses cell proliferation via inhibition of STAT3 phosphorylation and Mcl-1 and cIAP-2 expression in HTLV-1-infected T cells.
    Suzuki Y; Ito S; Sasaki R; Asahi M; Ishida Y
    Leuk Res; 2013 Dec; 37(12):1674-9. PubMed ID: 24090995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deguelin suppresses cell proliferation via the inhibition of survivin expression and STAT3 phosphorylation in HTLV-1-transformed T cells.
    Ito S; Oyake T; Murai K; Ishida Y
    Leuk Res; 2010 Mar; 34(3):352-7. PubMed ID: 19781773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical efficacy of sepantronium bromide (YM155) in multiple myeloma is conferred by down regulation of Mcl-1.
    Wagner V; Hose D; Seckinger A; Weiz L; Meißner T; Rème T; Breitkreutz I; Podar K; Ho AD; Goldschmidt H; Krämer A; Klein B; Raab MS
    Oncotarget; 2014 Nov; 5(21):10237-50. PubMed ID: 25296978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markedly additive antitumor activity with the combination of a selective survivin suppressant YM155 and alemtuzumab in adult T-cell leukemia.
    Chen J; Pise-Masison CA; Shih JH; Morris JC; Janik JE; Conlon KC; Keating A; Waldmann TA
    Blood; 2013 Mar; 121(11):2029-37. PubMed ID: 23321252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YM155 induces EGFR suppression in pancreatic cancer cells.
    Na YS; Yang SJ; Kim SM; Jung KA; Moon JH; Shin JS; Yoon DH; Hong YS; Ryu MH; Lee JL; Lee JS; Kim TW
    PLoS One; 2012; 7(6):e38625. PubMed ID: 22723871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HTLV-1 bZIP Factor RNA and Protein Impart Distinct Functions on T-cell Proliferation and Survival.
    Mitobe Y; Yasunaga J; Furuta R; Matsuoka M
    Cancer Res; 2015 Oct; 75(19):4143-52. PubMed ID: 26383166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dimethyl Fumarate Induces Apoptosis
    Maeta T; Sato T; Asano K; Ito S
    Anticancer Res; 2022 May; 42(5):2301-2309. PubMed ID: 35489748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YM155 induces caspase-8 dependent apoptosis through downregulation of survivin and Mcl-1 in human leukemia cells.
    Feng W; Yoshida A; Ueda T
    Biochem Biophys Res Commun; 2013 May; 435(1):52-7. PubMed ID: 23618862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YM155 induces apoptosis through downregulation of specificity protein 1 and myeloid cell leukemia-1 in human oral cancer cell lines.
    Sachita K; Yu HJ; Yun JW; Lee JS; Cho SD
    J Oral Pathol Med; 2015 Nov; 44(10):785-91. PubMed ID: 25475012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of YM155, a survivin suppressant with a STAT3 inhibitor: a new strategy to treat diffuse large B-cell lymphoma.
    Kaneko N; Kita A; Yamanaka K; Mori M
    Leuk Res; 2013 Sep; 37(9):1156-61. PubMed ID: 23746965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of YM155, a selective small-molecule survivin suppressant, alone and in combination with docetaxel in human malignant melanoma models.
    Yamanaka K; Nakahara T; Yamauchi T; Kita A; Takeuchi M; Kiyonaga F; Kaneko N; Sasamata M
    Clin Cancer Res; 2011 Aug; 17(16):5423-31. PubMed ID: 21737502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arsenic trioxide and the growth of human T-cell leukemia virus type I infected T-cell lines.
    Ishitsuka K; Hanada S; Uozumi K; Utsunomiya A; Arima T
    Leuk Lymphoma; 2000 May; 37(5-6):649-55. PubMed ID: 11042529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of constitutively active Jak-Stat pathway suppresses cell growth of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells.
    Tomita M; Kawakami H; Uchihara JN; Okudaira T; Masuda M; Matsuda T; Tanaka Y; Ohshiro K; Mori N
    Retrovirology; 2006 Apr; 3():22. PubMed ID: 16603085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YM155 Down-Regulates Survivin and Induces P53 Up-Regulated Modulator of Apoptosis (PUMA)-Dependent in Oral Squamous Cell Carcinoma Cells.
    Yan X; Su H
    Med Sci Monit; 2017 Apr; 23():1963-1972. PubMed ID: 28435150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells.
    Tao YF; Lu J; Du XJ; Sun LC; Zhao X; Peng L; Cao L; Xiao PF; Pang L; Wu D; Wang N; Feng X; Li YH; Ni J; Wang J; Pan J
    BMC Cancer; 2012 Dec; 12():619. PubMed ID: 23267699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual induction of apoptotic and autophagic cell death by targeting survivin in head neck squamous cell carcinoma.
    Zhang L; Zhang W; Wang YF; Liu B; Zhang WF; Zhao YF; Kulkarni AB; Sun ZJ
    Cell Death Dis; 2015 May; 6(5):e1771. PubMed ID: 26018732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of YM155, a selective survivin suppressant, in combination with cisplatin in hepatoblastoma.
    Yu Y; Zhao X; Zhang Y; Kang Y; Wang J; Liu Y
    Oncol Rep; 2015 Jul; 34(1):407-14. PubMed ID: 25955434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting survivin with YM155 (Sepantronium Bromide): a novel therapeutic strategy for paediatric acute myeloid leukaemia.
    Smith AM; Little EB; Zivanovic A; Hong P; Liu AK; Burow R; Stinson C; Hallahan AR; Moore AS
    Leuk Res; 2015 Apr; 39(4):435-44. PubMed ID: 25659731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular inhibitor of apoptosis protein 1 (cIAP1) stability contributes to YM155 resistance in human gastric cancer cells.
    Jung SA; Park YM; Hong SW; Moon JH; Shin JS; Lee HR; Ha SH; Lee DH; Kim JH; Kim SM; Kim JE; Kim KP; Hong YS; Choi EK; Lee JS; Jin DH; Kim T
    J Biol Chem; 2015 Apr; 290(16):9974-85. PubMed ID: 25635055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.